Serimmune - Mapping Human Immunity
Home | Tufts Lyme Disease Initiative
Mercedes de Guardiola
Home - Lyme X
10 teams are participating in a virtual accelerator designed to help them refine their concepts for detecting active Lyme disease infections in people.
The goal of the LymeX Diagnostics Prize is to develop diagnostics that can accurately detect active Lyme disease infections in people. The multiphase competition will nurture the development of innovative solutions toward Food and Drug Administration review. The first phase awarded $1 million, and the second phase will award up to $2 million. At the discretion of HHS and the Steven & Alexandra Cohen Foundation, and subject to availability of future funding, at least one additional phase may follow Phase 2.
Phase 1 was open to all eligible entrants to submit concept papers and plans for development. In Phase 2, 10 teams are participating in a virtual accelerator to help them refine their concepts.
Serimmune - Mapping Human Immunity
Home | Tufts Lyme Disease Initiative
Mercedes de Guardiola
Home - Lyme X